Heartland Advisors Inc. Makes New Investment in Henry Schein, Inc. $HSIC

Heartland Advisors Inc. bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 120,000 shares of the company’s stock, valued at approximately $9,070,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. MAI Capital Management lifted its holdings in shares of Henry Schein by 7.5% during the 3rd quarter. MAI Capital Management now owns 2,061 shares of the company’s stock valued at $137,000 after purchasing an additional 144 shares in the last quarter. Truist Financial Corp lifted its holdings in shares of Henry Schein by 3.3% during the 3rd quarter. Truist Financial Corp now owns 5,540 shares of the company’s stock valued at $368,000 after purchasing an additional 175 shares in the last quarter. HB Wealth Management LLC lifted its holdings in shares of Henry Schein by 1.3% during the 4th quarter. HB Wealth Management LLC now owns 15,034 shares of the company’s stock valued at $1,136,000 after purchasing an additional 191 shares in the last quarter. Czech National Bank lifted its holdings in shares of Henry Schein by 0.8% during the 4th quarter. Czech National Bank now owns 26,386 shares of the company’s stock valued at $1,994,000 after purchasing an additional 206 shares in the last quarter. Finally, Jain Global LLC lifted its holdings in shares of Henry Schein by 2.0% during the 3rd quarter. Jain Global LLC now owns 10,662 shares of the company’s stock valued at $708,000 after purchasing an additional 207 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 1.5%

NASDAQ:HSIC opened at $78.85 on Thursday. The firm has a market capitalization of $8.98 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 1.54 and a beta of 0.82. Henry Schein, Inc. has a twelve month low of $61.94 and a twelve month high of $89.29. The stock’s 50 day moving average price is $75.07 and its two-hundred day moving average price is $76.13. The company has a quick ratio of 0.75, a current ratio of 1.36 and a debt-to-equity ratio of 0.59.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.12. The firm had revenue of $3.37 billion for the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities research analysts expect that Henry Schein, Inc. will post 5.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. JPMorgan Chase & Co. lifted their price objective on Henry Schein from $78.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Wall Street Zen cut Henry Schein from a “strong-buy” rating to a “buy” rating in a report on Sunday, April 26th. BTIG Research assumed coverage on Henry Schein in a report on Thursday, April 16th. They set a “neutral” rating on the stock. Leerink Partners reiterated a “market perform” rating on shares of Henry Schein in a report on Monday, March 9th. Finally, Citigroup assumed coverage on Henry Schein in a report on Wednesday, April 15th. They set a “buy” rating and a $100.00 price objective on the stock. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Henry Schein has a consensus rating of “Hold” and an average target price of $86.83.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Thomas C. Popeck sold 1,355 shares of the business’s stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $72.79, for a total transaction of $98,630.45. Following the transaction, the chief executive officer owned 86,182 shares of the company’s stock, valued at $6,273,187.78. The trade was a 1.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William K. Daniel purchased 10,000 shares of the stock in a transaction on Monday, May 11th. The shares were bought at an average cost of $69.19 per share, for a total transaction of $691,900.00. Following the transaction, the director directly owned 20,000 shares in the company, valued at approximately $1,383,800. The trade was a 100.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.89% of the stock is owned by insiders.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.